Linc AB (LINC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Linc AB (LINC) has a cash flow conversion efficiency ratio of -0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.09 Million ≈ $-655.60K USD) by net assets (Skr4.51 Billion ≈ $485.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Linc AB market capitalisation for the company's overall valuation and market capitalisation.
Linc AB - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Linc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Linc AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Linc AB ranked by their cash flow conversion efficiency. Explore LINC cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Doubledown Interactive Co Ltd
NASDAQ:DDI
|
0.044x |
|
China Zhonghua Geotechnical Engineering Co Ltd
SHE:002542
|
-0.022x |
|
Antofagasta PLC
LSE:ANTO
|
0.043x |
|
First Copper Technology Co Ltd
TW:2009
|
-0.011x |
|
Colony Bankcorp Inc.
NYSE:CBAN
|
0.023x |
|
Gladstone Capital Corporation
NASDAQ:GLAD
|
-0.102x |
|
Inst Diagnosti
SN:INDISA
|
0.040x |
|
PetroVietnam Transportation Corp
VN:PVT
|
0.088x |
Annual Cash Flow Conversion Efficiency for Linc AB (2018–2025)
The table below shows the annual cash flow conversion efficiency of Linc AB from 2018 to 2025. View LINC stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr4.43 Billion ≈ $476.85 Million |
Skr4.25 Million ≈ $457.91K |
0.001x | -84.37% |
| 2024-12-31 | Skr4.83 Billion ≈ $519.86 Million |
Skr29.68 Million ≈ $3.19 Million |
0.006x | +126.91% |
| 2023-12-31 | Skr3.53 Billion ≈ $379.78 Million |
Skr-80.57 Million ≈ $-8.67 Million |
-0.023x | +70.88% |
| 2022-12-31 | Skr2.91 Billion ≈ $313.12 Million |
Skr-228.15 Million ≈ $-24.55 Million |
-0.078x | +19.49% |
| 2021-12-31 | Skr3.63 Billion ≈ $390.96 Million |
Skr-353.84 Million ≈ $-38.08 Million |
-0.097x | -1560.96% |
| 2020-12-31 | Skr2.49 Billion ≈ $268.42 Million |
Skr-14.63 Million ≈ $-1.57 Million |
-0.006x | -929.67% |
| 2019-12-31 | Skr1.66 Billion ≈ $178.75 Million |
Skr1.17 Million ≈ $126.34K |
0.001x | +103.83% |
| 2018-12-31 | Skr1.06 Billion ≈ $114.60 Million |
Skr-19.65 Million ≈ $-2.11 Million |
-0.018x | -- |
About Linc AB
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and o… Read more